<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Right heart failure: Clinical manifestations and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Right heart failure: Clinical manifestations and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Right heart failure: Clinical manifestations and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Barry A Borlaug, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Donna Mancini, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Todd F Dardas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 03, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2620721887">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Right heart failure (RHF) is a clinical syndrome in which symptoms and signs are caused by dysfunction of the right heart structures (predominantly the right ventricle [RV] but also the tricuspid valve apparatus and right atrium) or pericardium, resulting in impaired ability of the right heart to perfuse the lungs at normal central venous pressures [
         <a href="#rid1">
          1-3
         </a>
         ]. The terms RHF and RV dysfunction are not synonymous, as some patients have asymptomatic RV dysfunction, and not all RHF is caused by RV dysfunction. Many specific cardiovascular disorders lead to the clinical syndrome of RHF through a variety of mechanisms.
        </p>
        <p>
         This topic will address unique aspects of pathophysiology, clinical manifestation, and diagnosis of RHF. Evaluation of the cause and management of RHF are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/127128.html" rel="external">
          "Right heart failure: Causes and management"
         </a>
         .)
        </p>
        <p>
         Other aspects of HF are discussed separately, including the diagnosis and evaluation of HF, management of HF with reduced ejection fraction (HFrEF), and management of HF with preserved ejection fraction (HFpEF). (See
         <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">
          "Heart failure: Clinical manifestations and diagnosis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3485.html" rel="external">
          "Determining the etiology and severity of heart failure or cardiomyopathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/121085.html" rel="external">
          "Overview of the management of heart failure with reduced ejection fraction in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3504.html" rel="external">
          "Heart failure with preserved ejection fraction: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3461.html" rel="external">
          "Treatment and prognosis of heart failure with preserved ejection fraction"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1128898159">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         RHF may develop acutely or chronically and may be caused by acquired or congenital forms of cardiovascular disease [
         <a href="#rid1">
          1,2
         </a>
         ]. The most common causes of RHF are acquired forms of left-sided HF, particularly HFpEF and various causes of HFrEF. Evaluation of patients with RHF to identify the cause is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/127128.html" rel="external">
          "Right heart failure: Causes and management", section on 'Evaluating the cause of right heart failure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H309145307">
         <span class="h1">
          PREVALENCE AND DEMOGRAPHICS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The broad array of causes of the clinical syndrome of RHF and the lack of standardized definitions [
         <a href="#rid3">
          3
         </a>
         ] make it difficult to reach precise estimates on the prevalence of RHF, but it is highly prevalent in patients with HFrEF or HFpEF. A meta-analysis estimated the prevalence of RV dysfunction in patients with HFrEF at 48 percent [
         <a href="#rid4">
          4
         </a>
         ]. In HFpEF, the prevalence of RV dysfunction is estimated to be somewhat lower at 20 to 40 percent, depending upon the method used to assess RV function [
         <a href="#rid5">
          5-7
         </a>
         ]. However, RV function may deteriorate during exercise as compared with rest [
         <a href="#rid8">
          8,9
         </a>
         ], so even among patients with left-sided HF and normal RV function at rest, there may be significant impairments in RV functional reserve during exercise [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Among patients with HF, patient characteristics associated with RHF and RV dysfunction include higher pulmonary artery pressures, higher left atrial pressure, lower left ventricular (LV) ejection fraction, coronary artery disease, male sex, obesity, pulmonary disease, sleep-disordered breathing, and diabetes mellitus [
         <a href="#rid5">
          5,6,11,12
         </a>
         ]. Among patients with HFpEF, additional clinical features associated with RHF include atrial fibrillation and evidence of left atrial remodeling [
         <a href="#rid5">
          5,11,13,14
         </a>
         ]. In a study of 271 patients with HFpEF, development of atrial fibrillation was the strongest risk factor predicting incident development of RV dysfunction [
         <a href="#rid11">
          11
         </a>
         ]. Opening of the pericardium in patients undergoing cardiac surgery has been found to cause a reduction in longitudinal RV function and a gain in transverse shortening [
         <a href="#rid15">
          15
         </a>
         ]. Chronic kidney disease is commonly associated with RHF, and this relationship is believed to be in part related to
         <strong>
         </strong>
         renal venous hypertension caused by elevated central venous pressures [
         <a href="#rid16">
          16-18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13606.html" rel="external">
          "Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology", section on 'Increased renal venous pressure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3619929936">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pulmonary circulation is a high compliance, low resistance vascular bed that accommodates a large volume of blood flow with minimal increase in pressures under normal conditions [
         <a href="#rid19">
          19
         </a>
         ]. As such, the RV normally ejects blood at very low pressure, as compared with the much thicker-walled LV. Thus, the RV is generally far more afterload sensitive than the LV [
         <a href="#rid19">
          19,20
         </a>
         ]. For this reason, acute increases in pulmonary artery (PA) pressure, such as that caused by acute pulmonary embolism, may precipitate cardiogenic shock because the RV cannot generate sufficient pressure to maintain pulmonary perfusion [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8253.html" rel="external">
          "Epidemiology and pathogenesis of acute pulmonary embolism in adults", section on 'Pathophysiologic response to PE'
         </a>
         .)
        </p>
        <p>
         With chronic, sustained increases in PA pressure (as in most acquired forms of RHF), there are hypertrophic adaptations in the RV that allow for maintenance of forward flow despite the increase in RV afterload [
         <a href="#rid1">
          1,20
         </a>
         ]. Overtime, this adaptive hypertrophy progresses and becomes maladaptive, leading to RV dilation and progressive myocardial dysfunction [
         <a href="#rid11">
          11
         </a>
         ]. With increasing RV volumes, there is dilation of the tricuspid valve apparatus, causing functional tricuspid regurgitation. This further increases the volume load in the right atrium and RV, promoting further dilation and increasing severity of tricuspid regurgitation as part of a vicious cycle [
         <a href="#rid11">
          11
         </a>
         ]. Atrial fibrillation often develops in the setting of progressive atrial enlargement, but the relationship is bidirectional, as atrial fibrillation also leads to worsening RV dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/8119.html" rel="external">
          "Etiology, clinical features, and evaluation of tricuspid regurgitation", section on 'Pathophysiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/977.html" rel="external">
          "The management of atrial fibrillation in patients with heart failure", section on 'mechanisms of cardiac dysfunction'
         </a>
         .)
        </p>
        <p>
         Right-sided chamber dilation increases total heart volume, but total heart size is constrained by the pericardium, which cannot acutely enlarge as much as the heart. Pericardial constraint can cause near equalization of diastolic pressures in the left and right sides of the heart [
         <a href="#rid20">
          20,22,23
         </a>
         ]. The RV and LV share common muscle fibers in the interventricular septum, and RV dysfunction may compromise LV diastolic filling by shifting the septum from right to left in a process termed "diastolic ventricular interaction" [
         <a href="#rid22">
          22
         </a>
         ]. In this setting, left-sided cardiac pressures are elevated, but the LV may still be relatively underfilled due to excessive RV congestion, particularly during exercise as RV volumes further increase due to enhanced venous return [
         <a href="#rid9">
          9
         </a>
         ]. Similarly, LV systolic function may be impaired in the setting of RHF through systolic ventricular interaction [
         <a href="#rid5">
          5,24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/120068.html" rel="external">
          "Approach to evaluation of the right ventricle in adults", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p>
         Impaired RV systolic function, increasing tricuspid valve regurgitation, and impaired LV filling reduce forward stroke volume and cardiac output [
         <a href="#rid9">
          9
         </a>
         ]. This leads to neurohormonal activation that promotes renal sodium and water retention [
         <a href="#rid25">
          25
         </a>
         ]. The consequent volume overload and myocardial dysfunction cause marked elevation in central venous pressure. This increases hydrostatic pressures in the tissues and reduces lymph flow. This reduces fluid removal from the interstitial and alveolar spaces of the lungs, promoting development of pulmonary edema [
         <a href="#rid26">
          26
         </a>
         ]. Systemic venous hypertension elsewhere in the body leads to gut and lower extremity edema, ascites, and liver dysfunction from congestive hepatopathy that may progress to cirrhosis [
         <a href="#rid27">
          27
         </a>
         ]. Increases in central venous pressure also increase renal vein pressure and play a key role in promoting cardiorenal syndrome [
         <a href="#rid16">
          16-18,28
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3592.html" rel="external">
          "Congestive hepatopathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13606.html" rel="external">
          "Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3628640094">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2015265420">
         <span class="h2">
          Common clinical settings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with RHF typically have an antecedent history of known left-sided HF, valve disease, pulmonary hypertension, or congenital heart disease. However, some patients will present with de novo symptoms and signs of RHF (such as unexplained ascites or dyspnea) to primary care physicians and non-cardiology specialty clinics, such as gastroenterology or pulmonary medicine.
        </p>
        <p class="headingAnchor" id="H1146250027">
         <span class="h2">
          Symptoms and signs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Symptoms are often nonspecific and similar to those in patients with left-sided HF, but often more severe [
         <a href="#rid1">
          1,2
         </a>
         ]. Dyspnea on activity and increased fatigability with activity are common. Orthopnea and paroxysmal nocturnal dyspnea may be reported in patients with biventricular HF. Patients may also complain of chest discomfort, which often resembles angina, caused by elevation in intracardiac pressures that reduces coronary perfusion pressure and may cause subendocardial ischemia. Patients describe abdominal distention, anorexia, and early satiety due to hepatosplanchnic congestion and gut edema. Exercise capacity is characteristically depressed in patients with RHF due to left HF or other causes [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p>
         Physical examination is notable for jugular venous distention, often with a prominent V wave and positive Kussmaul sign. Lower extremity edema (generally bilateral and pitting) is usually present. Patients may appear cachectic, with loss of muscle mass despite stable or increased body weight, due to worsening fluid retention. Abdominal distention with a positive fluid wave (consistent with ascites) and hepatomegaly may be seen. Common findings on cardiac examination include an RV heave on palpation in the precordial region, a loud P2 sound (caused by pulmonary hypertension), and a murmur of tricuspid regurgitation (generally a holosystolic murmur over the left lower sternal border). (See
         <a class="medical medical_review" href="/z/d/html/1076.html" rel="external">
          "Examination of the jugular venous pulse"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1081.html" rel="external">
          "Examination of the precordial pulsation", section on 'Right ventricular impulse'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1079.html" rel="external">
          "Auscultation of heart sounds", section on 'Factors determining the intensity of S2'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">
          "Auscultation of cardiac murmurs in adults", section on 'Tricuspid regurgitation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H749773597">
         <span class="h2">
          Initial tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Initial tests include serum electrolytes, complete blood count (which often reveals anemia), tests of kidney function (blood urea nitrogen and serum creatinine), liver biochemical tests, an electrocardiogram, and a chest radiograph. Measurement of the level of plasma natriuretic peptide (B-type natriuretic peptide or N-terminal proBNP) is suggested if a diagnosis of HF is uncertain. (See
         <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">
          "Heart failure: Clinical manifestations and diagnosis in adults", section on 'Natriuretic peptide'
         </a>
         .)
        </p>
        <p>
         In patients with chronic RHF, kidney function tests typically reveal evidence of chronic kidney disease, often with marked elevation in blood urea nitrogen relative to serum creatinine. (See
         <a class="medical medical_review" href="/z/d/html/2359.html" rel="external">
          "Assessment of kidney function"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13606.html" rel="external">
          "Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         Congestive hepatopathy caused by RHF commonly causes elevation in serum bilirubin, which is generally mild but can be severe with acute severe RHF. Serum alkaline phosphatase levels are usually normal or minimally elevated with acute RHF, but greater elevations may be seen with chronic severe RHF. Serum aminotransferase levels are elevated in about one-third of patients with congestive hepatopathy. Hypoalbuminemia is observed in some patients but does not correlate with the degree of histologic liver damage and may be caused by malnutrition and protein-losing gastroenteropathy caused by elevated lymphatic pressure. Mild elevation in the prothrombin time is commonly seen and may be caused by impaired hepatic synthetic function as well as other factors. (See
         <a class="medical medical_review" href="/z/d/html/3592.html" rel="external">
          "Congestive hepatopathy", section on 'Laboratory testing'
         </a>
         .)
        </p>
        <p>
         Electrocardiography may reveal atrial fibrillation and/or evidence of RV strain, with T-wave inversions in the anterior precordial leads. (See
         <a class="medical medical_review" href="/z/d/html/2123.html" rel="external">
          "ECG tutorial: Chamber enlargement and hypertrophy", section on 'Right ventricular hypertrophy'
         </a>
         .)
        </p>
        <p>
         Levels of plasma natriuretic peptides are generally elevated in patients with RHF, but these markers do not distinguish between RHF and left-sided HF. (See
         <a class="medical medical_review" href="/z/d/html/3486.html" rel="external">
          "Natriuretic peptide measurement in heart failure"
         </a>
         .)
        </p>
        <p>
         Chest radiography typically shows an enlarged right heart border, often accompanied by findings of left-sided HF. (See
         <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">
          "Heart failure: Clinical manifestations and diagnosis in adults", section on 'Chest radiograph'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3559344266">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H3340179450">
         <span class="h2">
          When to suspect right heart failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         RHF should be suspected in patients with symptoms and signs of RHF, particularly in the presence of an acute or chronic condition that may cause or precipitate RHF. (See
         <a class="local">
          'Common clinical settings'
         </a>
         above.)
        </p>
        <p>
         Evaluation of patients with left-sided HF (LHF) should include evaluation for RHF as, LHF is the most common cause of RHF [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">
          "Heart failure: Clinical manifestations and diagnosis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112486.html" rel="external">
          "Pulmonary hypertension due to left heart disease (group 2 pulmonary hypertension) in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1914661727">
         <span class="h2">
          Diagnostic criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         A clinical diagnosis of RHF is made when central venous pressure is elevated (&gt;10 mmHg) and there is evidence of right heart dysfunction or pericardial disease. We identify decompensated RHF if there is elevated central venous pressure together with reduced cardiac index (&lt;2.2 L/min/m
         <sup>
          2
         </sup>
         ) and/or reduced stroke volume index (&lt;38 mL/m
         <sup>
          2
         </sup>
         ). These hemodynamic findings are associated with adverse outcomes for RHF associated with a number of different causes, including various forms of pulmonary hypertension (PH) and congenital heart disease [
         <a href="#rid29">
          29-31
         </a>
         ].
        </p>
        <p>
         A definitive diagnosis of RHF requires invasive assessment, which is indicated when treatment decisions will be altered by the information. Since RHF is defined as a clinical syndrome caused by inability of the right heart to perfuse the lungs at normal filling pressures, the gold standard for diagnosis of RHF is direct demonstration of elevated RV filling pressure (central venous pressure), with or without a reduction in cardiac output [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="local">
          'Cardiac catheterization'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1025600925">
         <span class="h2">
          Diagnostic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic testing for RHF includes the above described clinical evaluation (history, physical examination, and initial laboratory testing to identify symptoms and signs of RHF) and tests to assess the right (and left) heart, starting with echocardiography with additional imaging as needed. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/120068.html" rel="external">
          "Approach to evaluation of the right ventricle in adults", section on 'Approach to evaluation of the RV'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2772966189">
         <span class="h3">
          Echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Echocardiography with Doppler plays an essential role in the evaluation of a patient with suspected RHF [
         <a href="#rid1">
          1,2
         </a>
         ]. The RV has a complex geometry, shaped like a triangle in the long axis and a crescent situated over the LV in the short axis. Therefore, RV volume is difficult to measure by echocardiography, but clinically relevant measures of RV dimension provide information on remodeling. RV systolic function is measured by a number of indices based upon 2D imaging, tissue Doppler, and strain imaging [
         <a href="#rid2">
          2,20,32
         </a>
         ]. Right atrial size, the size and collapsibility of the inferior vena cava, tricuspid regurgitation severity, and estimated pulmonary artery (PA) pressure all provide important information as to the severity of RV dysfunction, the degree of right heart congestion present, and the magnitude of coexisting PH. (See
         <a class="medical medical_review" href="/z/d/html/120068.html" rel="external">
          "Approach to evaluation of the right ventricle in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83974.html" rel="external">
          "Echocardiographic assessment of the right heart"
         </a>
         .)
        </p>
        <p>
         In patients with RHF following left ventricular assist device (LVAD) placement, LVAD device settings are adjusted to minimize interventricular septal bowing on echocardiography. (See
         <a class="medical medical_review" href="/z/d/html/87834.html" rel="external">
          "Management of long-term mechanical circulatory support devices", section on 'Right heart failure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H992454816">
         <span class="h3">
          Additional imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         If the results of echocardiography are non-diagnostic (technically suboptimal or otherwise limited), additional cardiac imaging is indicated. Cardiovascular magnetic resonance imaging (CMR) is generally the preferred advanced imaging approach to assess RV structure and function. (See
         <a class="medical medical_review" href="/z/d/html/120068.html" rel="external">
          "Approach to evaluation of the right ventricle in adults", section on 'Additional evaluation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4268013572">
         <span class="h4">
          Cardiovascular magnetic resonance imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         CMR is the most accurate method to quantify RV volumes, RV ejection fraction, and RV mass; it also enables assessment of regional RV and LV wall motion and myocardial scar and inflammation (via contrast enhancement) [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/120068.html" rel="external">
          "Approach to evaluation of the right ventricle in adults", section on 'Cardiovascular magnetic resonance'
         </a>
         .)
        </p>
        <p>
         Inflammation and tissue fibrosis may be evaluated using gadolinium-enhanced contrast imaging, but the role of such assessment is not established for general assessment of RHF. Use of gadolinium-enhanced contrast imaging to assess myocardial disease is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5314.html" rel="external">
          "Clinical utility of cardiovascular magnetic resonance imaging", section on 'Gadolinium contrast techniques'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2774193124">
         <span class="h4">
          Computed tomography
         </span>
         <span class="headingEndMark">
          —
         </span>
         If CMR is unavailable or contraindicated, or there is a concurrent indication for computed tomography (CT; such as suspected acute pulmonary embolism), cardiac CT may be used to assess RV size and function [
         <a href="#rid1">
          1
         </a>
         ]. However, CT entails exposure to ionizing radiation exposure.
        </p>
        <p class="headingAnchor" id="H2832940513">
         <span class="h4">
          Radionuclide imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Radionuclide imaging is less commonly used in the current era given poorer spatial resolution as compared with CMR and CT but may provide useful information when performed for other indications (eg, stress testing to evaluate ischemic heart disease).
        </p>
        <p class="headingAnchor" id="H1309511304">
         <span class="h4">
          Right upper quadrant ultrasonography
         </span>
         <span class="headingEndMark">
          —
         </span>
         The role of ultrasonography and other testing in confirming a diagnosis of congestive hepatopathy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3592.html" rel="external">
          "Congestive hepatopathy", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1347288138">
         <span class="h3">
          Cardiac catheterization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cardiac catheterization is the definitive test to diagnose RHF and is indicated when this information cannot be determined using noninvasive tests and is required for treatment decisions [
         <a href="#rid33">
          33,34
         </a>
         ]. Right heart catheterization enables direct quantification of left and right heart filling pressures, PA pressures, pulmonary and systemic vascular resistances, and cardiac output. Left heart catheterization enables assessment of LV end-diastolic pressures as well as coronary angiography.
        </p>
        <p>
         Cardiac catheterization is helpful in identifying the cause of RHF (particularly PH and its hemodynamic causes, acute or chronic ischemic heart disease, pericardial disease, and RHF following LVAD placement), as discussed further separately. (See
         <a class="medical medical_review" href="/z/d/html/127128.html" rel="external">
          "Right heart failure: Causes and management", section on 'Evaluating the cause of right heart failure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2937087395">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis for RHF includes a variety of other conditions that cause similar clinical features but can generally be distinguished by history, physical examination, cardiac imaging and other tests:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vena cava obstruction or stenosis presents with clinical manifestations like those with RHF, with subacute or acute symptoms and signs of venous obstruction or insufficiency in the absence of associated cardiac and pericardial disease. Vena cava obstruction is confirmed by imaging, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2832.html" rel="external">
          "Malignancy-related superior vena cava syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15223.html" rel="external">
          "Overview of iliocaval venous obstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/17036.html" rel="external">
          "Overview of thoracic central venous obstruction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other causes of bilateral pitting lower extremity edema include nephrotic syndrome, bilateral deep venous thrombosis, and medications (such as dihydropyridine calcium channel blockers). These other causes of peripheral edema are distinguished from RHF by absence of evidence of elevated central venous pressure and right heart dysfunction, as well as evidence of other causes (such as proteinuria in nephrotic syndrome, history and signs consistent with DVT, and medication history). (See
         <a class="medical medical_review" href="/z/d/html/6878.html" rel="external">
          "Clinical manifestations and evaluation of edema in adults", section on 'Patients with bilateral leg edema'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other causes of ascites include cirrhosis, cancer, and tuberculosis  (
         <a class="graphic graphic_table graphicRef56069" href="/z/d/graphic/56069.html" rel="external">
          table 1
         </a>
         ). Patients with ascites should undergo a diagnostic paracentesis. In patients with congestive hepatopathy, there is typically a high ascitic protein content (generally &gt;2.5 g/dL). (See
         <a class="medical medical_review" href="/z/d/html/1261.html" rel="external">
          "Evaluation of adults with ascites"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3592.html" rel="external">
          "Congestive hepatopathy", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The differential diagnosis of congestive hepatopathy includes other causes of liver disease, including viral hepatitis and hemochromatosis; evaluation of these alternate causes is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3592.html" rel="external">
          "Congestive hepatopathy", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3165028278">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115372.html" rel="external">
          "Society guideline links: Heart failure in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2873107878">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and etiologies
         </strong>
         – Right heart failure (RHF) is a clinical syndrome in which symptoms and signs are caused by dysfunction of the right heart structures (predominantly the right ventricle [RV], but also the tricuspid valve apparatus and right atrium) or pericardial disease resulting in impaired ability of the right heart to perfuse the lungs at normal central venous pressures. RHF may develop acutely or chronically and may be caused by acquired or congenital forms of cardiovascular disease. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence and demographics
         </strong>
         –
         <strong>
         </strong>
         Although the overall prevalence of RHF has not been fully defined, RHF is highly prevalent in patients with HF with reduced ejection fraction or HF with preserved ejection fraction. (See
         <a class="local">
          'Prevalence and demographics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathophysiology
         </strong>
         – Acute increases in pulmonary artery pressure cause acute RHF and may result in cardiogenic shock, since the RV is far more afterload sensitive than the left ventricle (LV). (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Chronic RHF is most commonly caused by chronic RV pressure and/or volume overload, which causes progressive RV remodeling, leading to RV dilation and myocardial dysfunction, commonly associated with progressive functional tricuspid regurgitation. RV dilation and pericardial constraint may in turn compromise LV diastolic and systolic function. (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Common clinical settings
         </strong>
         – Patients with RHF typically have an antecedent history of known left-sided HF, valve disease, pulmonary hypertension, or congenital heart disease, although some patients will present with de novo symptoms and signs of RHF (such as unexplained ascites or dyspnea) to primary care physicians and non-cardiology specialty clinics. (See
         <a class="local">
          'Common clinical settings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Clinical manifestations of RHF include dyspnea, fatigue chest discomfort, abdominal distention with a positive fluid wave, jugular venous distention, a right ventricular heave, a loud P2, and murmur of tricuspid regurgitation (a holosystolic murmur over the left lower sternal border). Marked elevation in blood urea nitrogen relative to serum creatinine is commonly seen in patients with chronic RHF. Congestive hepatopathy caused by RHF commonly causes elevation in serum bilirubin. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic criteria
         </strong>
         – A clinical diagnosis of RHF is made when the central venous pressure is elevated (&gt;10 mmHg) and there is evidence of right heart dysfunction or pericardial disease. An invasive evaluation is indicated when treatment decisions will be altered by the information. A definitive diagnosis of RHF is made by direct invasive demonstration of elevated RV filling pressure (central venous pressure). (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2018; 137:e578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorter TM, van Veldhuisen DJ, Bauersachs J, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018; 20:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehra MR, Park MH, Landzberg MJ, et al. Right heart failure: toward a common language. J Heart Lung Transplant 2014; 33:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iglesias-Garriz I, Olalla-Gómez C, Garrote C, et al. Contribution of right ventricular dysfunction to heart failure mortality: a meta-analysis. Rev Cardiovasc Med 2012; 13:e62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melenovsky V, Hwang SJ, Lin G, et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014; 35:3452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohammed SF, Hussain I, AbouEzzeddine OF, et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 2014; 130:2310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorter TM, Hoendermis ES, van Veldhuisen DJ, et al. Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail 2016; 18:1472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995; 25:1143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorter TM, Obokata M, Reddy YNV, et al. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease. Eur Heart J 2018; 39:2825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borlaug BA, Kane GC, Melenovsky V, Olson TP. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. Eur Heart J 2016; 37:3293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Obokata M, Reddy YNV, Melenovsky V, et al. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction. Eur Heart J 2019; 40:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghio S, Guazzi M, Scardovi AB, et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail 2017; 19:873.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melenovsky V, Hwang SJ, Redfield MM, et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail 2015; 8:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorter TM, van Melle JP, Rienstra M, et al. Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation. J Card Fail 2018; 24:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raina A, Vaidya A, Gertz ZM, et al. Marked changes in right ventricular contractile pattern after cardiothoracic surgery: implications for post-surgical assessment of right ventricular function. J Heart Lung Transplant 2013; 32:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Damman K, van Deursen VM, Navis G, et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009; 53:582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Testani JM, Khera AV, St John Sutton MG, et al. Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 2010; 105:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guazzi M, Borlaug BA. Pulmonary hypertension due to left heart disease. Circulation 2012; 126:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008; 117:1436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belenkie I, Dani R, Smith ER, Tyberg JV. Effects of volume loading during experimental acute pulmonary embolism. Circulation 1989; 80:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borlaug BA, Reddy YNV. The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment. JACC Heart Fail 2019; 7:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117:1717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frenneaux M, Williams L. Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. Prog Cardiovasc Dis 2007; 49:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy YNV, Obokata M, Wiley B, et al. The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction. Eur Heart J 2019; 40:3721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sundaram V, Fang JC. Gastrointestinal and Liver Issues in Heart Failure. Circulation 2016; 133:1696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Testani JM, Chen J, McCauley BD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weatherald J, Boucly A, Chemla D, et al. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Circulation 2018; 137:693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egbe AC, Bonnichsen C, Reddy YNV, et al. Pathophysiologic and Prognostic Implications of Right Atrial Hypertension in Adults With Tetralogy of Fallot. J Am Heart Assoc 2019; 8:e014148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miranda WR, Borlaug BA, Hagler DJ, et al. Haemodynamic profiles in adult Fontan patients: associated haemodynamics and prognosis. Eur J Heart Fail 2019; 21:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jain CC, Borlaug BA. Hemodynamic assessment in heart failure. Catheter Cardiovasc Interv 2020; 95:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen MJ, Borlaug BA. Invasive hemodynamic characterization of heart failure with preserved ejection fraction. Heart Fail Clin 2014; 10:435.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 126513 Version 7.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29650544" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29044932" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24268184" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Right heart failure: toward a common language.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23160163" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Contribution of right ventricular dysfunction to heart failure mortality: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24875795" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Right heart dysfunction in heart failure with preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25391518" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27650220" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7897128" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29947750" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27354047" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30544228" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27860029" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25593126" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29197548" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23773508" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Marked changes in right ventricular contractile pattern after cardiothoracic surgery: implications for post-surgical assessment of right ventricular function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19215833" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19215832" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20152246" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22908015" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Pulmonary hypertension due to left heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18347220" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2736750" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Effects of volume loading during experimental acute pulmonary embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31248569" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18378625" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17185113" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10451464" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Hormones and hemodynamics in heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31609443" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27143152" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Gastrointestinal and Liver Issues in Heart Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20606118" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29070502" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31701796" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Pathophysiologic and Prognostic Implications of Right Atrial Hypertension in Adults With Tetralogy of Fallot.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30672076" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Haemodynamic profiles in adult Fontan patients: associated haemodynamics and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20620859" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31507065" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Hemodynamic assessment in heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24975907" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Invasive hemodynamic characterization of heart failure with preserved ejection fraction.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
